Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q2 2021 · 10-Q
Revenue—
Net Income-$869.30K-$869.30KN/M vs Q2 2020 EPS Diluted-$0.01-$0.01N/M vs Q2 2020 Operating Income-$633,792N/M Operating Cash Flowderived-$310,910N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Jan 31, 2021 · filed Mar 11, 2021 · 39 d after period end